December 17, 2014 / 7:52 AM / 3 years ago

BRIEF-Orexo receives 5 mln GBP milestone payment for Abstral in Europe

Dec 17 (Reuters) - Orexo AB

* Orexo receives million 5£ milestone payment for Abstral in Europe and Zubsolv continues strong market share growth in the U.S.

* The last four weeks Zubsolv has reached 5.6% of the market (daily dosages) compared to 4.2% the last month of Q3 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below